SCOPUS BIOPHARMA INC (SCPS)

US8091711015 - Common Stock

0.1682  -0.17 (-50.54%)

After market: 0.12 -0.05 (-28.66%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
16.40M19.53M10.13M2.69M690.00K
Research and Development
2.07M6.92M7.39M460.00K280.00K
Selling, General, and Administrative Expenses
14.33M12.61M2.73M2.23M410.00K
Operating Income
-16.40M-19.53M-10.13M-2.69M-690.00K
Interest Income/Expense
0.00681.21K-710.00KN/AN/A
Non Recurring Items
N/A-8.10M-30.00KN/AN/A
Income Before Taxes
-16.40M-26.95M-10.86M-2.69M-690.00K
Net Income
-16.40M-26.95M-10.86M-2.69M-690.00K
EBITDA
-16.40M-19.53MN/AN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-0.81-1.56-0.81-0.19-0.05
 
Statistics

All data in USD

Charts